From NAM AIDSmap, Roger Pebody reports on two Toronto studies that shed light on how PrEP stigma is affecting PrEP uptake.

Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first, young gay men acknowledged that they did not always use condoms but did not see themselves as the kind of ‘barebacker’ for whom they thought PrEP was intended.
“PrEP embodies the notion of bareback sex, which traditionally has been associated with negative elements, and it is quite clear that the young gay men in this re

It shows gaps and fissures within our heath-care delivery system,' activist says of Truvada coverage. From CBC News, this report by Angela Sterritt.

Two-spirit activist Harlan Pruden says First Nations organizations failed Indigenous people by not disseminating enough information about a groundbreaking HIV/AIDS treatment.
When two-spirit organizer and HIV/AIDS activist Harlan Pruden heard the news that the preventative drug PrEP was now available cost-free in B.C. he was elated. "It's phenomenal news that B.C.'s community now has access to this evidence-based, effective HIV prevention intervention," Pruden said.
But he said v

Once-daily pill contains two anti-HIV drugs that reduce the risk of sexual transmission of virus

Generic versions of pre-exposure prophylaxis or PrEP to prevent HIV are becoming more available in Canada. (CBC)
To read the complete article, visit CBC News, here.
Ontario will soon cover a combination HIV prevention pill that is now available in generic form, HIV advocates say. The once-daily pill contains two anti-HIV drugs that reduce the risk of sexual transmission in HIV-negative individuals.
Pre-exposure prophylaxis, or PrEP, originally cost about $1,000 a month as the brand nam

“I thought that we needed something bolder, something sexier, and something that reflected the realities of gay sex...”

Mr. Leather LA 2014 and LA County HIV Commission member Eric Paul Leue Photo: John Kiffmeyer
To read the complete article by Chris Tipton-King visit Huffington Post, here.
If you weren’t aware that Gilead recently started running Truvada for PrEP ads, I wouldn’t blame you: they’re exactly the sort of vanilla, stock-photo-and-fine-print yawners that you might expect from a pharmaceutical company. For a prevention strategy meant for men who enjoy dicks in butts au-natural, most

Advocates and doctors are scrambling to understand exactly when the generic will become available and how much it will cost. From TheBody.com, Sony Salzman reports.

To read the complete article by Sony Salzman, vsit TheBody.com, here.
The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become available and how much it will cost.
After weeks of speculation, both of those questions remain unanswered -- locked behind a confidential settlement agreement between TEVA,

Sexual health advocates hope this will make widen access to PrEP, the medication that helps prevent people contracting HIV

To read the complete article by David Hudson visit Gay Star News, here.
The Food and Drug Administration (FDA) in the US has approved the first generic form of PrEP. PrEP is medication that can be taken by someone to prevent them becoming infected with HIV. It’s a daily pill of Truvada, produced by Gilead Sciences. Truvada is a combination of Emtricitabine and Tenofovir Disoproxil Fumarate
The use of PrEP has been credited with driving down HIV infection rates in countries where it has

From KALW.org, Chloe Lessard: "some women and trans folks are wondering why a drug that could potentially save their lives hasn’t been aggressively promoted in their communities."

To read the complete article by Chloe Lessard, visit KALW.org, here.
Did you know that you can take a drug to reduce your risk of getting HIV? If you’re a gay man, you’ve probably heard of it. It’s a daily regimen called PrEP, or pre-exposure prophylaxis. Maybe you’ve even seen ads for it on BART trains or clinic brochures, usually targeting men who sleep with other men. But PrEP doesn’t only benefit men, and some women and trans folks are wondering why a drug that could potential

From The Advocate: educating people about the availability of PrEP shouldn't be controversial, writes Dr. Michael Gottlieb.

The complete article by Dr. Michael Gottlieb can be read at The Advocate, here.
As a physician who has been treating people with HIV since the beginning of the epidemic and as a witness to more than a few AIDS-related controversies, I’m profoundly puzzled by how some are overreacting to a new HIV prevention campaign.
F*ck w/out Fear is the admittedly audacious tagline of the Los Angeles LGBT Center’s new campaign to raise awareness about pre-exposure prophylaxis, which consists of tak

On getting U=U and PrEP facts right .POZ reports on this joint initiative of Human Rights Campaign and Prevention Access Campaign.

This article previously appeared at POZ, here.
A new initiative called Accuracy Watchdog aims to correct erroneous reporting about HIV transmission risks. A partnership between LGBT advocacy group Human Rights Campaign (HRC) and Prevention Access Campaign (PAC), Accuracy Watchdog launched this month. The joint initiative will, for example, correct scientific misinformation pertaining to people living with HIV who are on treatment and maintain an undetectable viral load—a concept known as

Is the future all about implants, or will it offer multiple options for people who want to use PrEP? For AIDSmap.com, Keith Alcorn reports on several developments in PrEP delivery.

Last month’s announcement that the Bill and Melinda Gates Foundation will give up to $140 million to a Boston drug device manufacturer to develop an implantable mini-pump to deliver drugs for pre-exposure prophylaxis (PrEP) against HIV infection has focused attention on the future of PrEP. Is the future all about implants, or will it offer multiple options for people who want to use PrEP?
Implants and other long-acting drug delivery systems have attracted interest as a means of delivering P